跳至主要内容
临床试验/NCT04450108
NCT04450108已完成不适用

Clinical Study of the Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients Responding to Inhaled Corticosteroid (ICS) Treatment

Bosch Healthcare Solutions GmbH12 个研究点 分布在 1 个国家目标入组 122 人开始时间: 2020年9月8日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
122
试验地点
12
主要终点
Change in FeNO Value

研究概览

简要总结

This is a multi-center study to evaluate fractional exhaled nitric oxide (FeNO) measured with the Vivatmo pro in adult and pediatric subjects.

详细描述

Subjects will be screened, enrolled and tested at Study Visit #1 and then prescribed inhaled corticosteroid (ICS) treatment as per routine clinical care. Subjects will return for Study Visit #2 in two weeks and repeat fractional exhaled nitric oxide (FeNO) measured with the Vivatmo pro

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
7 Years 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject is 7 to 80 years of age.
  • Has been identified as a candidate for inhaled corticosteroid (ICS) treatment
  • Is willing and able to perform Vivatmo pro™ testing

排除标准

  • Subject has used corticosteroids prior to enrollment.
  • Subject has other current serious medical conditions
  • Subject has not been clinically stable for at least 2 weeks prior to the study
  • Subject is unwilling or unable to perform Vivatmo pro testing

结局指标

主要结局

Change in FeNO Value

时间窗: 14 days

Change in FeNO value before and after inhaled corticosteroid treatment

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (12)

Loading locations...

相似试验